Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Gadolinium Enhanced Brain Magnetic Resonance in the Follow Up of Metastatic Breast Cancer Patients Overexpressing HER2 Neu. A Randomized Prospective Study

NCT00398437 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT00398437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00398437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Gadolinium Enhanced Brain Magnetic Resonance in the Follow Up of Metastatic Breast Cancer Patients Overexpressing HER2 Neu. A Randomized Prospective Study
Lead sponsor
Jules Bordet Institute
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2006
Completion date
Not reported
Enrollment
96 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic cancer